hs preview webinar today et
barren wasteland alpha ex mco lab
cheat
remain remark difficult complex investor continu
debat deep valu vs valu trap spoiler alert trap win long
term structur question margin return competit continu domin
trade major investor uninvolv univers ex mco
occasion idiosyncrat stori think lh even bull worri
elect much democrat wave occur mean
presidenti elect well occasion fear blue price competit
thu short feast headlin drug price worri ftc disclosur
mix earn report think dynam unfortun stay
take year mani fear face busi prove
de-risk get use mix neg skew return fade
occasion bear market ralli luckili still cover life tool hire newshel
posit side ye sole full gloom doom upgrad
outperform add lab must-own sector overal along
tool devic mco like beneficiari improv volum
stabl price heighten fund flow get carri away
think gone soft also downgrad view legaci
express move under-perform somehow
legaci escap long term competit busi model disrupt
debat domin sector via multipl compress think
much longer given plethora excit privat entiti renew interest
larg tech close continu like cross
finger well st keep roll lab trade
volatil everyth els
rx suppli chain despit improv fundament head quarter sentiment
remain terribl get though volum growth continu trend upward
price rel stabl brand still hsd gener deflat trend hsd
vs time last year debat lt margin structur industri
continu strong amazon threat put seriou pressur
stock obvious dont expect stop time soon rather sporad
wreak havoc complex forese futur beyond distributor
front investor continu focu visibl meet guidance/outlook
year particularli margin progress given distributor idiosyncrat issu
group continu see upsid look increment
color pharmedium progress hd smith integr contribut
itll help counter major neg mix shift addit potenti
upsid option look forward commentari thought
regard compani serv pillpack distributor turn drug
store downgrad morn link note in-lin
view continu front-end pressur risk drug price uncertainti
eu fee pressur brexit volatil long-term margin remain concern
certainli camp believ emerg massiv threat
pharmaci overnight even medium-to-long term undeni
enter market bring plethora question
may prepar talk yet lastli pbm well look color
etc howev dont expect anyth materi outsid aforement esrx
like wont call suspend due role
link et webinar
continu next page
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
laboratori corp america
specialti lab hit ad quarter preview first time view shorter term data support
lt bullish view compani growth isi dental survey link recent note show volum tick slightli
sequenti anoth quarter equip purchas intent step regard ftc suit increas number
dentist believ outcom posit price anim health front proprietari market model show us
driver product growth cattl hog food price step point slightli moder growth
well look color move lab upgrad morn link note
outperform overal view pama contract clariti pois increment
volum captur market share gain turn aid margin oper incom growth lead shift ep growth
hsd coupl dividend yield offer tsr lab remain one healthcar servic
subsector ex mco invest point recommend group broadli lh appropri growth
 dividend growth hit built ehr contract tracker show ytd net win let us know
youd like see space still impact weak demand util monitor book momentum
close given slowli grow slowli grow industri transit saa cloud potenti increment
competit threat neg busi mix shift servic downgrad morn link
note under-perform despit continu opportun hospit share gain compani well-posit provid
 increment uncertainti va dod think lt structur question far outweigh posit
mco facil util trend still appear mute favor mco anoth round strong earn print
guidanc rais elev inpati acuiti report hospit rais question whether might broader util
uptick come claim report caught sign still point toward continu outmigr lower-acu servic outpati
strateg effort hospit attract share higher-acu admiss anoth concern mco potenti
aggress price non-profit given improv margin reserv level plu tax cut blue note reserv still
peak past cycl margin improv driven individu market still plenti
futur uncertainti reason caution expect messag call price still gener ration final
approach novemb midterm could hamper stock perform wave democrat victori amid call singl
payor medicar ultim view headlin risk broad disrupt chang unlik fundament
mco like remain posit provid increas focu control healthcar cost
last page report import disclosur regard stock report
broadli depress lab join lone mco sole invest sub-sector
rx wholesal face lt mix price question om
lab increasingli look like safe servic
specialti distribut plagu dental woe om risk
remain battl old guard vs emerg tech
bull bear debat healthcar distribut
volum like improv
om aid mix
consolid pick-up
dental volum steadi
capital-expenditure like improv
cycl acceler
risk real
death price cut
pama hit commerci
dso lt margin headwind
price risk ftc
medic anim set slow
reset notabl lower
big tech rescu
threat
bull bear debat manag facil
rel safeti servic
right side vbc trend
shift outpati
fundament suppli chain improv modestli
brand inflat remain hsd gener price continu stabil
total rx expect rise y-o-i
improv trend gener specialti volum
backdrop rx suppli chain trend favor fear lt margin
compress continu domin equiti
amazon pillpack acquisit investor debat impact
offici enter pharmaci market
pillpack miniscul market share
late june announc acquir
pillpack start-up on-line pharmaci deliv pre-
sort medic proprietari packag
deal term disclos price
reportedli bn deal expect close year
revenu
in-network
pharmaci licens
state hi
pharmaci ep sensit share loss
multipl hit justifi yr grocer larg recov
despit pillpack diminut size investor focus
potenti price compression/shar loss
assum lose share pillpack
would impli pillpack revenu growth cash
margin normal result ep hit includ lost
front-end attach sale could
pharmaci share loss gm
share level would requir seismic shift
competit corpor parent
abil make sizeabl invest
heighten investor fear weigh multipl
drug price blueprint overhang rx channel
list price requir advertis
restrict use rebat move fixed-pric
discount includ revisit safe harbor
fiduciari statu pbm
share medicar part rebat point sale
prohibit gag claus cash price cheaper
appli part negoti physician-
administ drug part
lower drug per class part formulari
value-bas purchas feder contract
address free-rid lower foreign price
brand manufactur share drug sampl
gener compani
fda discret safeti protocol
crack pay-for-delay arrang
request inform open thru juli
medicar rule propos expect fall
time use rebat buy formulari
access suggest may soon
come end examin
whether need disrupt entir
system rebat drive list price
ever higher patient keep pay
elimin rebat within medicar
program push system toward fixed-
price discount well within
remark coalit summer meet
azar
critic
incent
gross-to-net spread widen
 downgrad get pain train
current wall worri simpli high climb view
downgrad share walgreen outperform end one pain
experi endur year sell-sid analyst
typic hate reactiv downgrad least wait day post news case
realli struggl put togeth coher thesi outperform post
certainli camp believ emerg massiv threat
pharmaci overnight even medium long term howev see continu risk front
end believ market suffici amount worri long-term margin mean
termin valu could remain impair reflect compress multipl
current wall worri simpli high climb view risk join drug price
uncertainti front end eros eu fee pressur brexit volatil
furthermor sell side estim still appear high year oi perspect
consensu impli return profit growth beyond wrong algorithm view
thu number go may go long litani potenti headwind
unlik de-risk medium term thu keep multipl impair one actual get
improv return that ultim question could answer thu move
click full note publish morn
what go broader dental space
volum path normal
equip purchas intent step
past two month poll dentist
order gain better understand current state
upcom plan equip purchas dental
practic across us
amazon threat continu build momentum
dentist think ftc suit improv price
use least
purchas suppli
suppli purchas
awar complaint
macro data support lt bullish view growth
consum confid continu trend favor
share inflect w/ growth complex
anim health indic point sequenti slowdown
product anim growth like moder
anim health backdrop healthi downtick
includ cattl hog food soybean corn wheat
peer includ abax
 pet industri expenditur like lsd msd rang medium term w/hsic outperform
lead macro indic still solid volum growth nt
organ volum slow moder
medic lab spend continu step
clinic lab stock less expos specul relat risk within hc servic
 upgrad outperform
lab bastion safeti within tough hc servic tape offer rare mix low risk doubl digit tsr
last sever year featur epic turnaround share manag acceler
growth effect manag cost deploy capit eras nearli decad futil
multi-year bull run surprisingli interrupt unfavor outcom pama uncertainti
key contract re-pric also present potenti risk headwind ep
pama still remain hit price sizeabl windfal tax reform allow manag smooth
impact ep growth still sacrif invest busi
furthermor clariti respect aet turn net beneficiari
increment volum industri color price appear favor vs expect
would impli commerci govern price like remain stabl medium
term stark contrast remaind healthcar servic complex
addit see improv case market share gain increment volum lh
mix outright share gain non-pref vendor key contract tailwind
well step outreach pl deal smaller provid struggl new realiti
increment volum turn aid margin oper incom growth lead shift ep growth
high-singl digit potenti low doubl digit
coupl attract dividend yield offer tsr solidli doubl
digit surprisingli low risk profil
work rel valuat also suggest multipl lab improv time
settl rang vs recent histor
click full note publish morn
ehr vendor contract win loss ytd
gener contract win declin sinc epic/cern lead pack request tracker
sourc evercor isi kla report healthcareitnew ehrintellig american hospit directori vendor custom websit
 downgrad under-perform
despit contd oppti hospit share gain think long term structur qs far outweigh posit
given posit bia compani clear market leader along epic
decid dig recent hope find opportun share mani argu greater revenu
visibl margin inflect improv
unfortun work progress led us direct hadnt previous contempl sever
long-term issu aros heard debat frequent
first center around potenti financi impact busi model increasingli shift saa
cloud depress revenu growth margin mani legaci softwar vendor bias perpetu
second potenti increment competit threat emerg ventur back
vendor popul health analyt adjac push toward interoper open data
monopoli current enjoy epic often forc client purchas epic
analyt best breed offer challeng integr
thirdli busi mix shift servic much higher bia vs tradit softwar vendor help
sustain revenu growth carri low contribut margin high capital-expenditure requir
case host call question appropri multipl like long term
roll togeth see much greater degre nt ep uncertainti contempl prior
also wonder busi model look like year time mix perspect turn
right termin valu today properli captur higher multipl smaller base
thu despit continu opportun hospit share gain well posit provid
increment certainti va dod although ramp may back end load st contempl
think long term structur question far outweigh posit turn move under-perform share
ep forecast consensu respect pt move
impli downsid despit multipl target
click full note publish morn
util continu trend posit mco
monthli per capita util growth impli inflat data still mute notabl decreas april
weak volum slightli off-set higher price mco saw signific yoy decreas
higher inpati acuiti sign broad util uptick
acuiti strengthen hospit
hospit mostli acuiti uptick result inpati strategi mco ing notabl chang trend
companysourcecommentsuhsmay conf surgic procedur remain hospit definit skew acut procedur think reflect rise revenue-per-admiss number element think continu long inpatient-to-outpati shift continu sure go continu quit strong call call anyth unusu term acuiti anyth along line medic cost trend perform consist expect guidanc set back provid guidanc call inpati volum realli meaning expect come year obvious good thing see shift outpati set feel good perspect inpati trend overal combin util volum acuiti good posit feel good cost trend fact continu earn call continu posit thing us compani commentari around acuiti spike call also focus broadli high-acu servic less focus lower call would pick toward strateg approach develop servic line integr network yield growth slowdown transit inpati call would say think growth sustain would also say part grow acuiti well partial urgent care center ambulatori strategi lower acuiti stuff continu see exit call think see continu shift low-acu medic admiss shift inpati outpati increas think lose low-acu busi think higher-acu busi see specif medic admiss side cncjune inv day see signific chang chang trend juli
non-profit price focu rise margin
histor elev non-profit margin reserv level
neg lead indic underwrit cycl
improv financi non-profit plu corpor tax cut
benefit blue rais worri competit
price blue explicitli said plan price
back tax reform benefit see sign
reserv level rise peak prior cycl
better non-profit margin driven individu
market pull red futur stabil still uncertain
increment headwind mandat repeal
associ short-term plan expans
ratio closer average past peak
compani commentari around pricingcompanysourcecommentscimay conf first rel year ago year ago lot better inform flow technolog visibl cost profil futur think actual help lot two would point overal market competit ration last coupl year sign point someth differ conf blue peopl say oh abl compet reduc tax front-run go say subsid busi go thing way get reactiv somebodi els say go call would say point seen measur chang price relat tax juli
risk ci/esrx accret amazon entri mail pharmaci hh target rebat
lead-up drug
 pipelin vertic integr small horizont deal
acquir reliant
acquir scai
acquir healthsun
acquir dmg
stake knd
acquir banmdica
acquir
wcg acquir meridian
acquir
acquir american
acquir fide
acquir aet
ci acquir esrx
acquir abco hc
acquir america
stake
acquir sound
polit rhetor singl payor could make investor cautiou even real threat level low
democrat make healthcar issu top prioriti campaign potenti retak hous novemb success
would embolden call singl payor univers coverag
presidenti race start earnest next day medicar vari form support lead
bigger deficit tax cut higher spend increas risk futur budget reckon could affect healthcar
govern reli mco organ deliveri system control cost medicar advantag realist
worst case provid face hypothet pricing/margin risk
given like polit backlash cost disrupt real attempt implement view singl payor rhetor
headlin risk realist democrat prioriti exchang stabil medicar buy-in age could posit group
month pre- post-elect
note presidenti elect shown dot line
pt
focu quarter
feedback ci anti-trust updat
pt
focu quarter
pt
focu quarter
pbm buildout potenti
broader servic offer partner
risk adjust suspens
messag esrx post
amazon/pillpack drug price
nois time sharehold vote
pharmaci partnership home
articl articl
time dissemin juli et
analyst ross muken michael newshel elizabeth anderson matthew nicolai suzi yoon primarili respons prepar
research report attest follow view opinion render research report reflect person view
subject compani issuer part research analyst compens directli relat specif
recommend view research report
